相关实验视频

Updated: Sep 13, 2025

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

氧醇通过抑制ERBB家族和激酶通路,在3D黑色素瘤模型中重新编程瘤微环境

David Tovar-Parra^1,2, Marion Zammit Mangion^1,3

¹Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, MSD 2080 Msida, Malta.

International journal of molecular sciences

|July 29, 2025

概括

橄油中的一种化合物氧醇通过抑制癌细胞生长和关键信号通路,有效地对抗黑色素瘤. 它显示出作为向治疗的承诺,具有比dabrafenib更广泛的效果.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

恶性皮肤黑色素瘤是一种具有高转移潜力和耐治疗性的侵袭性皮肤癌.
来自橄油的氧醇具有抗癌特性,但其在3D黑色素瘤模型中的有效性在很大程度上是未知的.

研究的目的:

在3D黑色素瘤球形模型中研究氧醇的治疗潜力.
评估氧醇对黑色素瘤细胞活力,转移,侵入性,细胞循环,细胞亡和蛋白质组特征的影响.

主要方法:

使用非瘤 (HEMa) 和黑色素瘤 (C32) 细胞的对联3D球形模型.
进行了细胞毒性,转移,侵入性,细胞循环停止,细胞亡和蛋白质组测试.
与达布拉费尼布 (dabrafenib) 进行比较,将氧铁醇的作用进行了比较.

主要成果:

氧醇显著抑制了C32球状体的生长,降低了活力,诱导了细胞循环停止,并促进了细胞亡.
在HEMa模型中观察到最小的细胞毒性,表明选择性.
蛋白质组分析显示,瘤原蛋白 (ERBB2,ERBB3,ERBB4,VEGFR-2,WIF-1) 的下调,并抑制了PI3K-Akt/MAPK/ERK通路.

结论:

氧醇通过抑制酶信号传递和瘤-瘤相互作用来表现出多重向的抗黑色素瘤作用.
与dabrafenib相比,Hydroxytyrosol表现出更广泛的分子活性和更大的瘤细胞选择性.
这些发现支持氧醇作为黑色素瘤进展的潜在治疗剂.

关键词:

氧铁醇的使用方法这是黑色素细胞.黑色素瘤是一种黑色素瘤.蛋白质基质的保护性球形形状的球形状

更多相关视频

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.